We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Biocompatible Patch Repairs Heart Damage in Rat Model

By Gerald M. Slutzky, PhD
Posted on 13 Dec 2016
A team of Australian and British bioengineers has developed an electrically active biocompatible insert that can repair damage to electro-responsive tissues, such as the brain, heart, and nervous system without need of sutures.

Conducting polymers (CPs) are being considered as components of this type of biocompatible insert because of their intrinsic electroactive and flexible nature. More...
However, their clinical application has been largely hampered by their short operational time due to a decrease in their electronic properties.

To circumvent this problem investigators at the University of New South Wales (Sydney, Australia) and Imperial College London (United Kingdom) developed a novel CP scaffolding by growing polyaniline (PANI) doped with phytic acid on the surface of a chitosan film. Chitosan is a polysaccharide found in crab shells that is often used as a food additive; polyaniline is a conducting polymer; and phytic acid is a substance found in plants that is added to the polyaniline to switch it to its conducting state.

The investigators reported in the November 30, 2016, online edition of the journal Science Advances that the strong chelation between phytic acid and chitosan led to a conductive patch with retained electroactivity, low surface resistivity, and oxidized form after two weeks of incubation in physiological medium.

Ex vivo experiments revealed that the conductive nature of the patch had an immediate effect on the electrophysiology of the heart, while preliminary in vivo experiments in a rat model showed that the conductive patch did not induce proarrhythmogenic activities in the heart while it improved the conduction of electrical impulses across heart scar tissue.

"Our suture-less patch represents a big advance," said first author Dr. Damia Mawad, lecturer in materials science and engineering at the University of New South Wales. "We have shown it is stable and retains it conductivity in physiological conditions for more than two weeks, compared with the usual one day of other designs. No stitches are required to attach it, so it is minimally invasive and less damaging to the heart, and it moves more closely with the heart's motion. We envisage heart attack patients eventually having patches attached as a bridge between the healthy and the scar tissue, to help prevent cardiac arrhythmia. However, our patch is at the very early stages of this research. This technology can now be used for basic research to gain insights into the interface between the material and tissue."

Related Links:
University of New South Wales
Imperial College London

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Platelet Function Analyzer
PL-12
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.